{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:11:46Z","timestamp":1792120306525,"version":"4.4.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human induced pluripotent stem cells (iPSCs) bearing monogenic mutations have great potential for modeling disease phenotypes, screening candidate drugs, and cell replacement therapy provided the underlying disease-causing mutation can be corrected. Here, we report a homologous recombination-based approach to precisely correct the sickle cell disease (SCD) mutation in patient-derived iPSCs with 2 mutated \u03b2-globin alleles (\u03b2s\/\u03b2s). Using a gene-targeting plasmid containing a loxP-flanked drug-resistant gene cassette to assist selection of rare targeted clones and zinc finger nucleases engineered to specifically stimulate homologous recombination at the \u03b2s locus, we achieved precise conversion of 1 mutated \u03b2s to the wild-type \u03b2A in SCD iPSCs. However, the resulting co-integration of the selection gene cassette into the first intron suppressed the corrected allele transcription. After Cre recombinase-mediated excision of this loxP-flanked selection gene cassette, we obtained \u201csecondary\u201d gene-corrected \u03b2s\/\u03b2A heterozygous iPSCs that express at 25% to 40% level of the wild-type transcript when differentiated into erythrocytes. These data demonstrate that single nucleotide substitution in the human genome is feasible using human iPSCs. This study also provides a new strategy for gene therapy of monogenic diseases using patient-specific iPSCs, even if the underlying disease-causing mutation is not expressed in iPSCs.<\/jats:p>","DOI":"10.1182\/blood-2011-02-335554","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T12:09:34Z","timestamp":1314878974000},"page":"4599-4608","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":259,"title":["Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease"],"prefix":"10.1182","volume":"118","author":[{"given":"Jizhong","family":"Zou","sequence":"first","affiliation":[{"name":"Stem Cell Program, Institute for Cell Engineering;"},{"name":"Division of Hematology, Department of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Mali","sequence":"additional","affiliation":[{"name":"Stem Cell Program, Institute for Cell Engineering;"},{"name":"Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Huang","sequence":"additional","affiliation":[{"name":"Stem Cell Program, Institute for Cell Engineering;"},{"name":"Division of Hematology, Department of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Dowey","sequence":"additional","affiliation":[{"name":"Stem Cell Program, Institute for Cell Engineering;"},{"name":"Division of Hematology, Department of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzhao","family":"Cheng","sequence":"additional","affiliation":[{"name":"Stem Cell Program, Institute for Cell Engineering;"},{"name":"Division of Hematology, Department of Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111810312014900_B1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.stem.2009.11.009","article-title":"Technical challenges in using human induced pluripotent stem cells to model disease.","volume":"5","author":"Saha","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"7251","key":"2019111810312014900_B2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature08129","article-title":"Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.","volume":"460","author":"Raya","year":"2009","journal-title":"Nature"},{"issue":"1","key":"2019111810312014900_B3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.stem.2009.05.023","article-title":"Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.","volume":"5","author":"Zou","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"9","key":"2019111810312014900_B4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","article-title":"Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.","volume":"27","author":"Hockemeyer","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2019111810312014900_B5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbrc.2009.08.075","article-title":"Gene targeting in human pluripotent stem cells with adeno-associated virus vectors.","volume":"388","author":"Mitsui","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2019111810312014900_B6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/mt.2010.55","article-title":"Engineering of human pluripotent stem cells by AAV-mediated gene targeting.","volume":"18","author":"Khan","year":"2010","journal-title":"Mol Ther"},{"issue":"21","key":"2019111810312014900_B7","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1182\/blood-2010-12-328161","article-title":"Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.","volume":"117","author":"Zou","year":"2011","journal-title":"Blood"},{"issue":"5989","key":"2019111810312014900_B8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1194035","article-title":"Medicine. Sickle cell disease at 100 years.","volume":"329","author":"Orkin","year":"2010","journal-title":"Science"},{"key":"2019111810312014900_B9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/asheducation-2008.1.193","article-title":"Gene replacement therapy for sickle cell disease and other blood disorders.","author":"Townes","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"2019111810312014900_B10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1073\/pnas.0510177103","article-title":"Correction of the sickle cell mutation in embryonic stem cells.","volume":"103","author":"Chang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2019111810312014900_B11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells.","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"issue":"5858","key":"2019111810312014900_B12","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1152092","article-title":"Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.","volume":"318","author":"Hanna","year":"2007","journal-title":"Science"},{"issue":"4","key":"2019111810312014900_B13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/stem.402","article-title":"Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.","volume":"28","author":"Mali","year":"2010","journal-title":"Stem Cells"},{"issue":"27","key":"2019111810312014900_B14","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1182\/blood-2009-04-217406","article-title":"Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.","volume":"114","author":"Ye","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111810312014900_B15","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1634\/stemcells.2008-0346","article-title":"Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.","volume":"26","author":"Mali","year":"2008","journal-title":"Stem Cells"},{"issue":"3","key":"2019111810312014900_B16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/cr.2008.329","article-title":"Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models.","volume":"19","author":"Pomper","year":"2009","journal-title":"Cell Res"},{"issue":"12","key":"2019111810312014900_B17","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/blood-2009-11-252650","article-title":"Globin phenotype of erythroid cells derived from human induced pluripotent stem cells.","volume":"115","author":"Chang","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111810312014900_B18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3324\/haematol.2010.023556","article-title":"Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.","volume":"95","author":"Lapillonne","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"2019111810312014900_B19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/blood.V80.3.575.575","article-title":"Orkin SHGAT A-binding transcription factors in hematopoietic cells.","volume":"80","year":"1992","journal-title":"Blood"},{"issue":"1","key":"2019111810312014900_B20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1073\/pnas.94.1.169","article-title":"Mutation of gene-proximal regulatory elements disrupts human epsilon-, gamma-, and beta-globin expression in yeast artificial chromosome transgenic mice.","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2019111810312014900_B21","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1182\/blood.V95.10.3242","article-title":"Locus control region activity by 5\u2032HS3 requires a functional interaction with beta-globin gene regulatory elements: expression of novel beta\/gamma-globin hybrid transgenes.","volume":"95","author":"Rubin","year":"2000","journal-title":"Blood"},{"issue":"37","key":"2019111810312014900_B22","doi-asserted-by":"crossref","first-page":"13781","DOI":"10.1073\/pnas.0806976105","article-title":"Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.","volume":"105","author":"Suzuki","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111810312014900_B23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.stem.2009.11.016","article-title":"Modeling disease in human ESCs using an efficient BAC-based homologous recombination system.","volume":"6","author":"Song","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"16","key":"2019111810312014900_B24","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1073\/pnas.1103388108","article-title":"Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy.","volume":"108","author":"Howden","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111810312014900_B25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.stem.2011.04.019","article-title":"Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCs.","volume":"8","author":"Liu","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"7","key":"2019111810312014900_B26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/ng1373","article-title":"Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle.","volume":"36","author":"Kuroiwa","year":"2004","journal-title":"Nat Genet"},{"issue":"6034","key":"2019111810312014900_B27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/317230a0","article-title":"Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination.","volume":"317","author":"Smithies","year":"1985","journal-title":"Nature"},{"issue":"1","key":"2019111810312014900_B28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nmeth.1542","article-title":"Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA).","volume":"8","author":"Sander","year":"2011","journal-title":"Nat Methods"},{"issue":"2","key":"2019111810312014900_B29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing.","volume":"29","author":"Miller","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2019111810312014900_B30","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1073\/pnas.1008322108","article-title":"A hyperactive piggyBac transposase for mammalian applications.","volume":"108","author":"Yusa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2019111810312014900_B31","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1182\/blood-2009-03-191304","article-title":"Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.","volume":"114","author":"Kaufman","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111810312014900_B32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.blre.2009.10.001","article-title":"Autologous blood cell therapies from pluripotent stem cells.","volume":"24","author":"Lengerke","year":"2010","journal-title":"Blood Rev"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/17\/4599\/1463909\/zh804311004599.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/17\/4599\/1463909\/zh804311004599.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:04:07Z","timestamp":1574093047000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/17\/4599\/29067\/Sitespecific-gene-correction-of-a-point-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":32,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2011,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-02-335554","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,27]]}}}